Skip to the page

Data / Drug companies / Ulai Health LLC

Ulai Health LLC: 18 products in the FDA NDC directory, labeler code 73057

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Ulai Health LLC (labeler code 73057) lists 18 products in the FDA National Drug Code Directory, covering 17 finished drugs by generic name. By type: 18 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on January 31, 2024.

The request: Watch Ulai Health LLC (FDA labeler code 73057): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
73057
Products in commercial distribution
18
Packages
31
Finished drugs by generic name
17
Prescription products
0
Over the counter products
18
Flagged as original packager
18 of 18 products that carry the flag
Started marketing in the last 12 months
0
Earliest marketing start
June 26, 2019
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Over the counter monograph drugs18100%

Products by type

TypeProductsShare
Over the counter drugs18100%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

DrugProductsCompanies listing it
Acetaminophen 500mg25
Acetaminophen 500mg / diphenhydramine hcl 25mg11
Acetaminophen 325 mg11
Senna 8.6mg11
Diphenhydramine hcl 25mg12
Aspirin 325mg11
Calcium carbonate 10gr (648 mg)13
Guaifenesin 400mg13
Guaifenesin 400mg and dextromethorphan hbr 20mg12
Guaifenesin 400mg and phenylephrine hcl 10mg11
Polyvinyl alcohol 1.4%11
Chlorpheniramine maleate 4mg12
Sennosides 8.6mg and docusate sodium 50mg15
Meclizine hcl 12.5mg11
Diphenhydramine hcl 50mg13
Aspirin 81mg14
Mineral oil, white petrolatum ointment11

Dosage forms

Dosage formProductsShare
Tablet844.4%
Tablet, film coated316.7%
Capsule211.1%
Tablet, coated211.1%
Solution/ drops15.6%
Tablet, delayed release15.6%
Ointment15.6%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Vis Guard Lubricant Eye Drops73057-530Solution/ dropsOver the counter monograph drugsJanuary 31, 2024
Vis Guard Lubricant EyeOintment PM73057-510OintmentOver the counter monograph drugsJanuary 31, 2024
Pharbinex-PE73057-389Tablet, coatedOver the counter monograph drugsJuly 18, 2019
Pharbinex-DM73057-381TabletOver the counter monograph drugsJuly 18, 2019
Senna-S73057-378Tablet, film coatedOver the counter monograph drugsJuly 10, 2019
Senna-Tabs73057-363Tablet, film coatedOver the counter monograph drugsJuly 10, 2019
Meclizine73057-386TabletOver the counter monograph drugsJuly 8, 2019
Pharbetol73057-376TabletOver the counter monograph drugsJuly 8, 2019
Pharbetol73057-353TabletOver the counter monograph drugsJuly 8, 2019
Acetaminophen pm73057-352Tablet, film coatedOver the counter monograph drugsJuly 8, 2019
Pharbetol73057-350Tablet, coatedOver the counter monograph drugsJuly 8, 2019
Pharbedryl73057-347CapsuleOver the counter monograph drugsJuly 2, 2019
Calcium Carbonate 10 gr (648 mg) (Antacid)73057-377TabletOver the counter monograph drugsJuly 1, 2019
Allergy Relief 25 mg73057-348CapsuleOver the counter monograph drugsJuly 1, 2019
Pharbechlor73057-346TabletOver the counter monograph drugsJuly 1, 2019
Aspirin Regular Strength73057-365TabletOver the counter monograph drugsJune 28, 2019
Safety Coated Aspirin 81 mg Low Dose73057-356Tablet, delayed releaseOver the counter monograph drugsJune 28, 2019
Pharbinex73057-379TabletOver the counter monograph drugsJune 26, 2019

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.